Trial data suggests elacestrant – known by the brand name Korserdu – could increase how long people survive with one of the most common forms of breast cancer
Source link : https://www.mirror.co.uk/news/uk-news/breast-cancer-patients-denied-precious-33796527
Author : mirrornews@mirror.co.uk (Martin Bagot)
Publish date : 2024-10-01 19:12:48
Copyright for syndicated content belongs to the linked Source.
Breast cancer patients ‘denied precious time with loved ones’ as new drug Korserdu rejected on NHS
